MedPath
FDA Approval

Exemestane

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 19, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Exemestane(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Douglas Manufacturing Limited

Upsher-Smith Laboratories, Inc.

590829388

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Exemestane

Product Details

NDC Product Code
0832-0595
Application Number
ANDA209208
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 31, 2022
Code: NY22HMQ4BXClass: ACTIBQuantity: 25 mg in 1 1
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
hypromellose, unspecifiedInactive
Code: 3NXW29V3WOClass: IACT
sodium starch glycolate type A potatoInactive
Code: 5856J3G2A2Class: IACT
polyethylene glycol, unspecifiedInactive
Code: 3WJQ0SDW1AClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
crospovidone (120 .MU.M)Inactive
Code: 68401960MKClass: IACT
mannitolInactive
Code: 3OWL53L36AClass: IACT
microcrystalline celluloseInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath